ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
112.70
-0.10
(-0.09%)
終了 1月26日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
112.70
買値
112.50
売値
112.80
出来高
76,132
112.30 日の範囲 113.40
88.25 52 週間の範囲 114.70
時価総額
前日終値
112.80
始値
113.20
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
101,533
発行済株式数
117,946,146
配当利回り
0.75%
PER
37.17
1 株当たり利益 (EPS)
3.03
歳入
3.67B
純利益
357.6M

Biomerieux について

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Lyon, Rhone, Fra
設立
-
Biomerieux is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker BIM. The last closing price for Biomerieux was 112.80 €. Over the last year, Biomerieux shares have traded in a share price range of 88.25 € to 114.70 €.

Biomerieux currently has 117,946,146 shares in issue. The market capitalisation of Biomerieux is 13.30 € billion. Biomerieux has a price to earnings ratio (PE ratio) of 37.17.

BIM 最新ニュース

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the...

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches Aids hospitals in...

bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary & Extraordinary Shareholders’ Meeting...

Regulatory News: An Ordinary and Extraordinary Shareholders’ Meeting of bioMérieux (Paris:BIM) is called at 2:00 p.m. on May 20, 2021 at 376 Chemin de l'Orme, Marcy l'Étoile (69280...

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

Regulatory News: bioMérieux (Paris:BIM) : Code : BIM - Code ISIN : FR0013280286 Date d’arrêt des informations Nombre d’actions Nombre total de droits de vote   31/03/2021   118 361 220 Nombre...

bioMérieux annonce le marquage CE du test TB IGRA® (tuberculose) sur VIDAS®

Regulatory News: A l’occasion de la Journée mondiale de lutte contre la tuberculose, bioMérieux (Paris:BIM), acteur mondial dans le domaine du diagnostic in vitro, annonce le marquage CE de...

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

Regulatory News: bioMérieux (Paris:BIM), acteur majeur dans le domaine du diagnostic in vitro, annonce que sa filiale spécialisée dans les tests syndromiques des maladies infectieuses, BioFire...

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

Regulatory News: Le Document d’enregistrement universel incluant le rapport financier annuel au 31 décembre 2020 de bioMérieux (Paris:BIM) a été déposé auprès de l'Autorité des Marchés...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
12.72.45454545455110114.7109.3100013111.8813103DE
410.910.7072691552101.8114.7101.797445108.3746514DE
1210.29.9512195122102.5114.795.9101533102.75245566DE
2619.220.534759358393.5114.793.596679103.83898403DE
5210.19.8440545809102.6114.788.2599957100.65665533DE
15611.711.5841584158101114.777.4810362196.65121743DE
26026.7531.122745782485.95144.875116848102.76922446DE

BIM - Frequently Asked Questions (FAQ)

What is the current Biomerieux share price?
The current share price of Biomerieux is 112.70 €
How many Biomerieux shares are in issue?
Biomerieux has 117,946,146 shares in issue
What is the market cap of Biomerieux?
The market capitalisation of Biomerieux is EUR 13.3B
What is the 1 year trading range for Biomerieux share price?
Biomerieux has traded in the range of 88.25 € to 114.70 € during the past year
What is the PE ratio of Biomerieux?
The price to earnings ratio of Biomerieux is 37.17
What is the cash to sales ratio of Biomerieux?
The cash to sales ratio of Biomerieux is 3.62
What is the reporting currency for Biomerieux?
Biomerieux reports financial results in EUR
What is the latest annual turnover for Biomerieux?
The latest annual turnover of Biomerieux is EUR 3.67B
What is the latest annual profit for Biomerieux?
The latest annual profit of Biomerieux is EUR 357.6M
What is the registered address of Biomerieux?
The registered address for Biomerieux is CHEMIN DE L'ORME, MARCY L’ETOILE, LYON, RHONE, 69280
What is the Biomerieux website address?
The website address for Biomerieux is www.biomerieux.com
Which industry sector does Biomerieux operate in?
Biomerieux operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MLCOTCoretech 5
0.021 €
(61.54%)
102.18k
AELISAelis Farma SA
3.36 €
(46.09%)
24.42k
ALIMOGroupimo
0.182 €
(43.31%)
484
ALCWECharwood Energy SA
3.14 €
(36.52%)
10.6k
FPGUnion Tech Info
0.268 €
(26.42%)
11.65k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
818
ALTROTronic s Microsystems
3.90 €
(-28.44%)
23
ALNMRNamR SA
0.344 €
(-28.33%)
90.71k
GNROGeNeuro SA
0.1625 €
(-27.46%)
1.06M
ALOKWGroupe Okwind SA
3.30 €
(-20.29%)
35.38k
ATOAtos SE
0.0021 €
(0.00%)
1.18B
BCPBanco Comercial Portugues SA
0.5154 €
(-0.62%)
61.83M
ALCYBCybergun
0.0001 €
(0.00%)
56.47M
ALVERVergnet
0.0014 €
(0.00%)
19.39M
EDPEDP SA
2.901 €
(-0.65%)
13.72M

最近閲覧した銘柄

Delayed Upgrade Clock